Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor)
J A Neder, S Andreoni, C Peres, L E Nery, J A Neder, S Andreoni, C Peres, L E Nery
Abstract
Carbon monoxide diffusing capacity (DLCO) or transfer factor (TLCO) is a particularly useful test of the appropriateness of gas exchange across the lung alveolocapillary membrane. With the purpose of establishing predictive equations for DLCO using a non-smoking sample of the adult Brazilian population, we prospectively evaluated 100 subjects (50 males and 50 females aged 20 to 80 years), randomly selected from more than 8,000 individuals. Gender-specific linear prediction equations were developed by multiple regression analysis with single breath (SB) absolute and volume-corrected (VA) DLCO values as dependent variables. In the prediction equations, age (years) and height (cm) had opposite effects on DLCOSB (ml min-1 mmHg-1), independent of gender (-0.13 (age) + 0.32 (height) - 13.07 in males and -0.075 (age) + 0.18 (height) + 0.20 in females). On the other hand, height had a positive effect on DLCOSB but a negative one on DLCOSB/ VA (P < 0.01). We found that the predictive values from the most cited studies using predominantly Caucasian samples were significantly different from the actually measured values (P < 0.05). Furthermore, oxygen uptake at maximal exercise (VO2max) correlated highly to DLCOSB (R = 0.71, P < 0.001); this variable, however, did not maintain an independent role to explain the VO2max variability in the multiple regression analysis (P > 0.05). Our results therefore provide an original frame of reference for either DLCOSB or DLCOSB/VA in Brazilian males and females aged 20 to 80 years, obtained from the standardized single-breath technique.
Source: PubMed
Próximos ensayos clínicos
-
City of Hope Medical CenterNational Cancer Institute (NCI)Aún no reclutandoLinfoma no Hodgkin de células T maduras y células NK recidivante | Linfoma no Hodgkin de células T maduras y células NK refractario | Linfoma anaplásico de células grandes refractario | Linfoma anaplásico de células grandes recidivante | Linfoma de células T periférico refractario, no especificado y otras condicionesEstados Unidos
-
Rochester Institute of TechnologyNational Eye Institute (NEI)Aún no reclutandoMonochromatic | L- and S-cone Modulation Only | L- and M-cone Modulation Only | M and S-cone Modulation OnlyEstados Unidos
-
Yonsei UniversityAún no reclutandoPatients With Locally Advanced or Metastatic But Resectable Clear Cell Renal Cell Carcinoma
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; AstraZeneca; National Institutes of Health (NIH)Aún no reclutandoCáncer colonrectal | Adenocarcinoma de recto | Adenocarcinoma de ColonEstados Unidos
-
Minneapolis Heart Institute FoundationShockwave Medical, Inc.; HeartFlow, Inc.Aún no reclutandoEnfermedad de la arteria coronaria | ConnecticutEstados Unidos
-
Zhejiang Cancer HospitalAún no reclutandoColangiocarcinoma intrahepático (ICC)Porcelana
-
Tulane UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... y otros colaboradoresAún no reclutandoTrastorno hipertensivo del embarazo | Atención de salud maternaEstados Unidos
-
University of Health Sciences LahoreAún no reclutandoCannulation of Internal Jugular VeinPakistán
-
Centre Hospitalier Universitaire, AmiensCentral Hospital, Nancy, France; University Hospital, Caen; Clinique de l'Europe... y otros colaboradoresReclutamientoTrastornos musculoesqueléticos | CPRE | BiomechanicFrancia
-
Changhai HospitalAún no reclutando
-
Taiho Oncology, Inc.ReclutamientoLinfoma no Hodgkin de células BFrancia, Italia, Polonia, Estados Unidos, Australia, España
-
Tianjin Medical University Cancer Institute and...ReclutamientoTumor epitelial tímicoPorcelana